Lipitor and Ajovy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Ajovy (fremanezumab-vfrm). Common drug interactions include infusion site pain among females and dyspepsia among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Ajovy. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Ajovy?

Ajovy has active ingredients of fremanezumab-vfrm. eHealthMe is studying from 8,834 Ajovy users. Check the latest studies of Ajovy.



On Jul, 13, 2026

34 people who take Lipitor and Ajovy together, and have interactions are studied.

Lipitor and Ajovy drug interactions.

What are the common drug interactions of Lipitor and Ajovy, by gender? *:

female:

  1. Infusion site pain
  2. Insomnia (sleeplessness)
  3. Intervertebral disc disorder (spinal disc disorder)
  4. Irritability
  5. Lethargy (tiredness)
  6. Headache (pain in head)
  7. Migraine (headache)
  8. Fatigue (feeling of tiredness)
  9. Nausea (feeling of having an urge to vomit)
  10. Decreased appetite

male:

  1. Dyspepsia (indigestion)
  2. Dyspnoea (difficult or laboured respiration)
  3. Acne (skin problems that cause pimples)
  4. Alopecia (absence of hair from areas of the body)
  5. Arthralgia (joint pain)
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Drug ineffective
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Erythema (redness of the skin)
  10. Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Lipitor and Ajovy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Pancreatitis (inflammation of pancreas)

40-49:

  1. Spinal disorder (disease of spine a back bone)

50-59:

  1. Injection site mass
  2. Drug ineffective
  3. Dyspepsia (indigestion)
  4. Dyspnoea (difficult or laboured respiration)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pulmonary thrombosis (scarring in the lungs)
  7. Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
  8. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  9. Headache (pain in head)
  10. Muscle atrophy (a decrease in the mass of the muscle)

60+:

  1. Headache (pain in head)
  2. Fatigue (feeling of tiredness)
  3. Balance disorder
  4. Body tinea (ringworm of the body)
  5. Constipation
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Decreased activity
  8. Diarrhoea
  9. Diplopia (double vision)
  10. Dizziness

What are the existing conditions these people have? *

  1. Migraine (headache): 15 people, 44.12%
  2. Immunodeficiency Common Variable: 4 people, 11.76%
  3. Irritable Bowel Syndrome: 3 people, 8.82%
  4. Asthma: 3 people, 8.82%
  5. Muscle Spasms (muscle contraction): 2 people, 5.88%
  6. Immune System Disorder: 2 people, 5.88%
  7. Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 5.88%
  8. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 5.88%
  9. Gastric Ulcer (stomach ulcer): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Ajovy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Ajovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ajovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ajovy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and fremanezumab-vfrm (the active ingredients of Lipitor and Ajovy, respectively), and Lipitor and Ajovy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: